InvestorsHub Logo
Followers 883
Posts 304355
Boards Moderated 5
Alias Born 06/09/2006

Re: None

Friday, 11/21/2014 12:25:48 PM

Friday, November 21, 2014 12:25:48 PM

Post# of 197516
$VDRM TetraStem differentiates itself from other Tetracycline-based acne products by implementing a unique transdermal delivery method that the Company believes will increase the efficacy of the drug. TetraStem is designed to kill bacteria and heal the skin. ViaDerma believes that patients who apply a drop on the infected parts three times a day will see results within 24-48 hours and resolution within two weeks. TetraStem's active ingredient may help regenerate skin so there is minimal scarring which leaves the patient with very little evidence of previous acne problems.

"It has been tested in Florida, Oklahoma and California," said ViaDerma, Inc. CEO Dr. Christopher Otiko. "The subjects have been pleased with the results. They had tried other medication without success and were impressed with TetraStem's results."

http://finance.yahoo.com/news/viaderma-inc-lead-product-tetrastem-151643674.html

Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.